Patterns of Hepatocellular Carcinoma After Direct Antiviral Agents and Pegylated-Interferon Therapy-Reference-Cited by-同舟云学术

Patterns of Hepatocellular Carcinoma After Direct Antiviral Agents and Pegylated-Interferon Therapy

Published:2020-11-19 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Fatima Tehreem,Mumtaz Hassan,Khan Muhammad Hassaan,Rasool Saad,Tayyeb Muhammad,Haider Mobeen Z,Hussain Syed T,Shahzad Aamir,Ali Sundas,Hussain Tanveer

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference10 articles.

1. Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy;Khalid J;Infect Agent Cancer,2020

2. Efficacy and safety of sofosbuvir and ribavirin for treating chronic hepatitis C, genotype 3: experience of a tertiary care hospital at Karachi, Pakistan;Butt N;Cureus,2019

3. SVR rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China;Li Y;Virol J,2017

4. Changing patterns of hepatocellular carcinoma after treatment with direct antiviral agents;El Fayoumie M;Gastrointest Tumors,2020

5. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach JK;Hepatology,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in the course of hepatocellular carcinoma depending on the DAA treatment;Prospects in Pharmaceutical Sciences;2024-08-16

2. Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal;Hepatoma Research;2023

3. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects;Frontiers in Immunology;2021-10-04

4. Long-term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection;Hepatitis Monthly;2021-08-30